The National Cancer Institute’s Office of Cancer Clinical Proteomics Research (OCCPR) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) is pleased to announce the 2019 CPTAC Symposium, which offers an exciting opportunity to learn about the field of cancer proteogenomics and the strides in cancer research made by CPTAC investigators. 

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium is accepting applications for their Cancer Drug Discovery Data Scientist Fellowship program. This virtual information session will give potential applicants an opportunity to ask questions about the fellowship program and the application process.

NCI will host a webinar on October 8 to share updates regarding the Childhood Cancer Data Initiative (CCDI).

Dr. Adeyemo from the National Human Genome Research Institute (NHGRI) and Dr. Hull from the NIH Clinical Center will describe the potential advantages and disadvantages of ancestry testing as a surrogate for race and discuss the ethics of adopting such a practice in cancer research.

This workshop is intended to strengthen and expand NIH's innovation ecosystem by engaging researchers, practitioners, and other professionals interested in artificial intelligence healthcare across the nation's academic and industrial bases.

This webinar is intended for cancer researchers and bioinformaticians who are interested in learning more about the NCI Genomic Data Commons (GDC) bioinformatics pipelines supporting data harmonization.

Under the auspices of the Cancer Moonshot (sm), NCI welcomes advocates, policy leaders, and the public to participate in a two-day, multisession workshop to explore the impact of personal control of genomic data sharing to research, clinical care, and participants well-being and engagement.

The 2nd interactive virtual MicroLab will build on the breakout discussions from the 1st MicroLab. Participants will develop use cases based on the and identify the next critical steps that will help shape future research in computational oncology.

Dr. Yvonne Lau from the U.S. Department of Health and Human Services' Office for Human Research Protections (OHRP) will present about recent regulatory revisions to the Common Rule, 45 CFR part 46, concerning secondary research uses of biological samples and associated data.

Dr. Tony Kerlavage will be providing updates on the Childhood Cancer Data Initative at the 10th Annual Congressional Childhood Cancer Caucus Summit. He will be speaking alongside cancer research advocates, including 10-year-old cancer survivor Grace Eline, who spoke at the State of the Union Address earlier this year.